PhD in Regulatory Access for Leukodystrophy Therapies

SIGRA; Amsterdam; On-site; EUR 23,000 - 30,000; Full time

Job summary

Medicines Evaluation Board (MEB) in Utrecht, the Netherlands, hosts a POLARIS doctoral position embedded in the POLARIS consortium. The PhD student will study regulatory pathways and sustainable access to innovative therapies for rare diseases, supervised by Dr Marjon Pasmooij and in collaboration with Amsterdam UMC and other partners.

The project offers secondments across Europe, training opportunities in regulatory science, and a pathway to a PhD awarded by Vrije Universiteit Amsterdam.

Qualifications

• Master's degree in a discipline relevant to the project (medical or pharmaceutical sciences, biomedical sciences, health sciences, epidemiology or related).
• Interest in research at the intersection of rare diseases, regulatory science and access to therapies.
• Ability to work accurately and independently; ability to plan and organize research; good communication skills.

Responsibilities

• Initiate and conduct studies on regulatory pathways and sustainable access to innovative therapies for rare diseases.
• Use regulatory document analysis, expert interviews and case studies to integrate multiple perspectives.
• Undertake secondments to gain hands‑on regulatory science experience at partner institutions.
• Collaborate across Europe within the POLARIS doctoral network and with MEB and university partners.

Skills

Communication skills

English proficiency

Independent work

Research planning

Education

Master's degree in medical/pharmaceutical sciences or related field

Job description

Medicines Evaluation Board (MEB) in Utrecht, the Netherlands, hosts a POLARIS doctoral position embedded in the POLARIS consortium. The PhD student will study regulatory pathways and sustainable access to innovative therapies for rare diseases, supervised by Dr Marjon Pasmooij and in collaboration with Amsterdam UMC and other partners.

The project offers secondments across Europe, training opportunities in regulatory science, and a pathway to a PhD awarded by Vrije Universiteit Amsterdam.